Filing Details

Accession Number:
0001140361-11-005582
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-02 13:55:59
Reporting Period:
2011-01-31
Filing Date:
2011-02-02
Accepted Time:
2011-02-02 13:55:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1022079 Quest Diagnostics Inc DGX Services-Medical Laboratories (8071) 161387862
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1131399 Plc Glaxosmithkline 980 Great West Road
Brentford Middlesex X0 TW8 9GS
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Par Value, $0.01 Per Share Disposition 2011-01-31 15,377,600 $55.62 15,377,551 No 4 S Indirect By Corporation
Common Stock Par Value, $0.01 Per Share Disposition 2011-01-31 15,377,551 $54.30 0 No 4 S Indirect By Corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Corporation
No 4 S Indirect By Corporation
Footnotes
  1. Shares are held of record by SB Holdings Capital Inc., a wholly owned subsidiary of the Reporting Person.